BCYC
Price
$3.69
Change
-$0.05 (-1.34%)
Updated
Sep 25 closing price
Capitalization
261.07M
33 days until earnings call
Intraday BUY SELL Signals
IOVA
Price
$11.00
Change
+$0.20 (+1.85%)
Updated
Sep 25 closing price
Capitalization
4.89B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs IOVA

BCYC vs IOVA Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. IOVA commentary
Sep 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and IOVA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BCYC vs IOVA: Fundamental Ratings
BCYC
IOVA
OUTLOOK RATING
1..100
5943
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
8034
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (8) in the null industry is somewhat better than the same rating for IOVA (52) in the Biotechnology industry. This means that BCYC’s stock grew somewhat faster than IOVA’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as IOVA (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to IOVA’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as IOVA (97) in the Biotechnology industry. This means that BCYC’s stock grew similarly to IOVA’s over the last 12 months.

IOVA's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for BCYC (80) in the null industry. This means that IOVA’s stock grew somewhat faster than BCYC’s over the last 12 months.

IOVA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that IOVA’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCIOVA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 1 day ago
79%
COMPARISON
Comparison
Sep 26, 2026
Stock price -- (BCYC: $3.73 vs. IOVA: $11.00)
Brand notoriety: BCYC and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 252% vs. IOVA: 74%
Market capitalization -- BCYC: $261.07M vs. IOVA: $4.89B
BCYC [@Biotechnology] is valued at $261.07M. IOVA’s [@Biotechnology] market capitalization is $4.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.4B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green while IOVA’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • IOVA’s FA Score: 0 green, 5 red.
According to our system of comparison, IOVA is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while IOVA’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 6 bearish.
  • IOVA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +1.36% price change this week, while IOVA (@Biotechnology) price change was +7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.14%. For the same industry, the average monthly price growth was -13.22%, and the average quarterly price growth was +5.40%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

IOVA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BCYC
Daily Signal:
Gain/Loss:
IOVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GPZ21.890.20
+0.92%
Vaneck Alternative Asset Manager ETF
IWY297.201.34
+0.45%
iShares Russell Top 200 Growth ETF (IWY)
DANA25.020.09
+0.38%
Dana Limited Volatility ETF (DANA)
AOK40.690.14
+0.35%
iShares Core 30/70 Conservative Allocation ETF (AOK)
AVRY24.83-0.20
-0.80%
Avory Foundational ETF (AVRY)

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-1.21%
DNLI - BCYC
49%
Loosely correlated
-0.39%
PCVX - BCYC
48%
Loosely correlated
-1.21%
SANA - BCYC
47%
Loosely correlated
-0.51%
NGNE - BCYC
46%
Loosely correlated
-9.41%
BHVN - BCYC
46%
Loosely correlated
-1.52%
More

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
+1.85%
VCYT - IOVA
43%
Loosely correlated
-6.41%
PCVX - IOVA
41%
Loosely correlated
-1.21%
VIR - IOVA
41%
Loosely correlated
-0.56%
CRBU - IOVA
39%
Loosely correlated
-0.80%
BCYC - IOVA
38%
Loosely correlated
-1.21%
More